Julian S Gangolli
CIK 1532023 · President, North America · last filed 2025-10-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
6
Total Filings
49
Lifetime Open-Market Net
-$27.38M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OTLK | Director | — | $1.22 | — | $0 | 7 | 2025-10-03 |
| KRYS | Director | 0 | $317.97 | $0 | -$3.28M | 8 | 2025-06-30 |
| Revance Therapeutics, Inc. (RVNC) Delisted | Director | 15,000 | $3.65 | $54.8K | $0 | 11 | 2025-02-06 |
| Outlook Therapeutics, Inc. (OTLKW) Delisted | Director | — | $0.03 | — | $0 | 6 | 2021-10-07 |
| GW PHARMACEUTICALS PLC (GWPH) Delisted | President, North America | 117,336 | $218.96 | $25.69M | -$10.05M | 2 | 2019-05-14 |
| ALLERGAN INC (AGN) Delisted | CVP & Pres, North America | 22,496 | — | — | -$14.05M | 14 | 2015-02-24 |
Recent Filings · Page 4 of 5
49 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-02-28 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Mixed | +5,256 | -$74.7K | EDGAR |
| 2018-05-11 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | +3,000 | $0 | EDGAR |
| 2017-05-12 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | +3,000 | $0 | EDGAR |
| 2016-07-06 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-03-19 | — | Mixed | −22,713 | $0 | |
| 2015-02-24 | ALLERGAN INC (AGN) Delisted | Mixed | +245 | -$62.9K | EDGAR |
| 2015-02-19 | ALLERGAN INC (AGN) Delisted | Tax (F) | −1,150 | -$264.7K | EDGAR |
| 2014-03-07 | ALLERGAN INC (AGN) Delisted | Gift (G) | — | $0 | EDGAR |
| 2014-02-25 | ALLERGAN INC (AGN) Delisted | Mixed | −1,880 | -$235.1K | EDGAR |
| 2013-12-30 | ALLERGAN INC (AGN) Delisted | Mixed | — | -$2.96M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.